KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Jazz Pharmaceuticals (JAZZ) Inventory Average (2016 - 2025)

Jazz Pharmaceuticals has reported Inventory Average over the past 15 years, most recently at $450.0 million for Q4 2025.

  • Quarterly results put Inventory Average at $450.0 million for Q4 2025, down 11.74% from a year ago — trailing twelve months through Dec 2025 was $450.0 million (down 11.74% YoY), and the annual figure for FY2025 was $448.7 million, down 16.71%.
  • Inventory Average for Q4 2025 was $450.0 million at Jazz Pharmaceuticals, down from $494.0 million in the prior quarter.
  • Over the last five years, Inventory Average for JAZZ hit a ceiling of $1.2 billion in Q3 2021 and a floor of $105.4 million in Q1 2021.
  • Median Inventory Average over the past 5 years was $619.5 million (2023), compared with a mean of $664.2 million.
  • Biggest five-year swings in Inventory Average: skyrocketed 1198.87% in 2021 and later tumbled 34.76% in 2022.
  • Jazz Pharmaceuticals' Inventory Average stood at $1.1 billion in 2021, then tumbled by 34.76% to $721.1 million in 2022, then dropped by 16.18% to $604.4 million in 2023, then dropped by 15.64% to $509.9 million in 2024, then dropped by 11.74% to $450.0 million in 2025.
  • The last three reported values for Inventory Average were $450.0 million (Q4 2025), $494.0 million (Q3 2025), and $498.9 million (Q2 2025) per Business Quant data.